Skip to content

Public FDA record

K113020: IMMULISA ENHANCED (TM) CARDIOLIPIN IGA, IGG, IGM AND IGA/IGG/IGM ANTIBODY (ACA) ELISAS

510(k) clearance K113020 for Immco Diagnostics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
K113020
Company in FDA record
Immco Diagnostics, Inc.
FDA decision date
Oct 25, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026

Decision stated in the source

Substantially Equivalent

Source facts

Decision
Substantially Equivalent
Received
2011-10-11
Specialty
Immunology
Decision code
SESE
Clearance type
Traditional

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗